Results 121 to 130 of about 83,632 (216)

Mycobacterium avium Subsp. paratuberculosis and Human Endogenous Retrovirus in Italian Patients With Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)

Immunology, EarlyView.
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease (CD), is a recognised gastrointestinal disorder. Mycobacterium avium subspecies paratuberculosis (MAP) is implicated in IBD pathogenesis. Persistent exposure and active infections by MAP may contribute to the unsilencing of human endogenous retroviruses (HERV ...
Stefano Ruberto, Alfredo Santovito, Gian P. Caviglia, Marta Noli, Davide Cossu, Davide G. Ribaldone, Demis Pitoni, Simona Frara, Elisa Tribocco, Chiara Rosso, Marta Guriglia, Ilaria Cossu, Pier A. Tovo, Massimiliano Bergallo, Leonardo A. Sechi   +14 more
wiley   +1 more source

Brief communication: observations of falsely reactive antigen/antibody HIV screening results in an emergency department setting. [PDF]

AIDS Res Ther
Hare H, Holbrook E, Sarmento M, Haber R, Henderson H, McCoy B, Reale S, Lauster A, Wilson J.   +8 more
europepmc   +1 more source

Latent Neoehrlichia mikurensis Infections May Be Reactivated in Patients With B‐Cell Lymphomas Treated With Rituximab

Immunology, EarlyView.
Eight percent of this cohort of patients had a latent Neoehrlichia mikurensis infection. It was only the latently infected patients who had N. mikurensis‐specific T cells, not the matched B‐cell lymphoma patients without the infection. The T‐cell responses of latently infected patients included perforin‐expressing Th1 and CD8+ T cells that upregulated ...
Linda Wass, Catharina Lewerin, Daniel Jaén‐Luchoro, Christine Lingblom, Christine Wennerås   +4 more
wiley   +1 more source

Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain. [PDF]

BMC Infect Dis
Micó M, Trapé J, González-García L, Trujillo-Isern G, González-Fernández C, López-Madueño J, Bérgamo S, Pérez-Vidal R, Flor A, Martínez-Montero R, Rives J, Arnau A, Fàbrega A, Althaia Serology Group.   +13 more
europepmc   +1 more source

Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study

Journal of Diabetes Investigation, EarlyView.
Among adults with newly diagnosed type 2 diabetes in Kazakhstan, 25.8% showed islet autoantibody positivity, indicating a substantial autoimmune component. ZnT8 and GADA were the most prevalent, supporting the importance of immunological assessment for accurate diabetes classification.
Khatimya Kudabayeva, Bibigul Tleumagambetova, Yerlan Bazargaliyev, Lorina Vudu   +3 more
wiley   +1 more source

Natural SARS-CoV-2 infection in farmed minks <i>(Neovison vison)</i> causes lung pathology, systemic viral spread, and transmission risk, even in asymptomatic animals. [PDF]

Front Vet Sci
Vreman S, Giglia G, Molenaar RJ, Hakze-van der Honing R, Delemarre EM, Nierkens S, Wiese KE, Agliani G, van der Poel W, van Kuppeveld F, Bosch BJ, de Bruin E, Gröne A, de Bruijn N, van den Brand JMA.   +14 more
europepmc   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

To eradicate or not? <i>Helicobacter pylori</i> in patients with inflammatory bowel disease: an updated systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Bi Y, Zhou L, Zhou S, Sun Y, Zhang J.
europepmc   +1 more source

Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth, Joseph F. Merola, Richard Furie, Kenneth Kalunian, Ronald F. van Vollenhoven, Juanita Romero‐Diaz, Qianyun Li, Weihong Yang, Catherine Barbey   +8 more
wiley   +1 more source